Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Parietal scalp area has lower hair density and smaller hair diameter in women with hair loss.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Fat stem cells from diabetic mice can help heal skin wounds in other diabetic mice.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Somatostatin may help protect hair follicles from immune attacks.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

PRP injections increase hair density and diameter in female androgenetic alopecia patients.

The marine complex supplement significantly improved hair growth in men with thinning hair without adverse effects.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.